GTS Securities LLC

SEC CIK: 0001452765
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SABSW holding history

SAB Biotherapeutics, Inc. in every 13F filed by GTS Securities LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SABSW overview All 13F holders of SABSW Full Q2 2026 holdings

Shares (Q2 2026): 41,301
Value: $537
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of SABSW by GTS Securities LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	41,301	$537	<0.1%	+300+0.7%	Added	Holders
Q1 2026	41,001	$1.07K	<0.1%	−100−0.2%	Reduced	Holders
Q4 2025	41,101	$1.03K	<0.1%	+41,101	New	Holders